Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Annals of Pharmacotherapy
|
May 16, 1998
Symptomatic syndrome of inappropriate antidiuretic hormone secretion associated with azithromycin
P E Kintzel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 15, 1996
Amphotericin B in fat emulsion
P E Kintzel
Drug Safety
|
February 24, 2001
Anticancer drug-induced kidney disorders
P E Kintzel
The Annals of Pharmacotherapy
|
September 28, 2001
Prophylaxis for paclitaxel hypersensitivity reactions
P E Kintzel
American Journal of Hospital Pharmacy
|
May 1, 1992
Practical guidelines for preparing and administering amphotericin B
P E Kintzel, G H Smith
Clinical Pharmacy
|
February 1, 1991
Recombinant interleukin-2: a biological response modifier
P E Kintzel, K A Calis
American Journal of Hospital Pharmacy
|
August 1, 1991
Stability of amphotericin B in 5% dextrose injection at 25 degrees C
P E Kintzel, P E Kennedy
American Journal of Hospital Pharmacy
|
February 1, 1991
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line
P E Kintzel, P E Kennedy
Cancer Treatment Reviews
|
January 1, 1995
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
P E Kintzel, R T Dorr
The Annals of Pharmacotherapy
|
March 1, 1994
Otic administration of amphotericin B 0.25% in sterile water
P E Kintzel, D E Trausch, A L Copfer
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Annals of Pharmacotherapy
|
May 16, 1998
Symptomatic syndrome of inappropriate antidiuretic hormone secretion associated with azithromycin
P E Kintzel
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 15, 1996
Amphotericin B in fat emulsion
P E Kintzel
Drug Safety
|
February 24, 2001
Anticancer drug-induced kidney disorders
P E Kintzel
The Annals of Pharmacotherapy
|
September 28, 2001
Prophylaxis for paclitaxel hypersensitivity reactions
P E Kintzel
American Journal of Hospital Pharmacy
|
May 1, 1992
Practical guidelines for preparing and administering amphotericin B
P E Kintzel, G H Smith
Clinical Pharmacy
|
February 1, 1991
Recombinant interleukin-2: a biological response modifier
P E Kintzel, K A Calis
American Journal of Hospital Pharmacy
|
August 1, 1991
Stability of amphotericin B in 5% dextrose injection at 25 degrees C
P E Kintzel, P E Kennedy
American Journal of Hospital Pharmacy
|
February 1, 1991
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line
P E Kintzel, P E Kennedy
Cancer Treatment Reviews
|
January 1, 1995
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
P E Kintzel, R T Dorr
The Annals of Pharmacotherapy
|
March 1, 1994
Otic administration of amphotericin B 0.25% in sterile water
P E Kintzel, D E Trausch, A L Copfer
Page
of 2